Gene description for ERO1L |
Gene name |
ERO1-like (S. cerevisiae) |
Gene symbol |
ERO1L |
Other names/aliases |
ERO1-L ERO1-L-alpha ERO1-alpha ERO1A ERO1LA |
Species |
Homo sapiens |
Database cross references - ERO1L |
ExoCarta |
ExoCarta_30001 |
Entrez Gene |
30001 |
HGNC |
13280 |
MIM |
615435 |
UniProt |
Q96HE7
|
ERO1L identified in exosomes derived from the following tissue/cell type |
Bladder cancer cells
|
20224111
|
Liver cancer cells
|
25265333
|
Squamous carcinoma cells
|
20124223
|
Gene ontology annotations for ERO1L |
|
Experiment description of studies that identified ERO1L in exosomes |
1 |
Experiment ID |
76 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|GAPDH|HSP90
|
EV Cytosolic markers |
✔
CD81|CD9|CD63|LAMP1|MHCI
|
EV Membrane markers |
✔
HSP90B1
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20224111
|
Organism |
Homo sapiens |
Experiment description |
Proteomics analysis of bladder cancer exosomes. |
Authors |
Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A. |
Journal name |
MCP
|
Publication year |
2010 |
Sample |
Bladder cancer cells |
Sample name |
HT1376 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.10-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF/TOF] Western blotting FACS |
|
|
2 |
Experiment ID |
267 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
TSG101|Alix
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✔
CANX|HSP90B1
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25265333
|
Organism |
Homo sapiens |
Experiment description |
Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh‑7 Cells Using SILAC Labeling and LC−MS/MS |
Authors |
Zhao X, Wu Y, Duan J, Ma Y, Shen Z, Wei L, Cui X, Zhang J, Xie Y, Liu J |
Journal name |
J Proteome Res
|
Publication year |
2014 |
Sample |
Liver cancer cells |
Sample name |
Huh-7 - Transfected with HBx plasmids |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
3 |
Experiment ID |
191 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
Alix
|
EV Cytosolic markers |
✔
CD81|CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20124223
|
Organism |
Homo sapiens |
Experiment description |
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. |
Authors |
Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2010 |
Sample |
Squamous carcinoma cells |
Sample name |
Squamous carcinoma cell (A431) |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for ERO1L |
|
Pathways in which ERO1L is involved |
|
|
|